AJCC	American Joint Committee on Cancer
ALK	Anaplastic lymphoma kinase
BMI	Body mass index
CHT-ICI	Chemo-immunotherapy
CI	Confidence interval
COPD	Chronic obstructive pulmonary disease
CT	Computed tomography
CTCAEs	Common Terminology Criteria for Adverse Events
DFS	Disease-free survival
EAP	Expanded access program
EBUS	Endobronchial ultrasound
ECOG	Eastern Cooperative Oncology Group
EFS	Event-free survival
EGFR	Epidermal growth factor receptor
EUS	Endoscopic ultrasonography
IASLC	International Association for the Study of Lung Cancer
ICI	Immune checkpoint inhibitor
ICU	Intensive care unit
LA-NSCLC	Locally advanced non-small cell lung cancer
MIS	Minimally invasive surgery
MPR	Major pathological response
MRI	Magnetic resonance imaging
NSCLC	Non-small cell lung cancer
NPR	No pathological response
OR	Odds ratio
OS	Overall survival
pCR	Pathological complete response
PD-L1	Programmed death-ligand 1
PET-CT	Positron emission tomography/computed tomography
PPR	Partial pathological response
RCT	Randomized controlled trial
STROBE	Strengthening the Reporting of Observational Studies in Epidemiology
TNM	Tumor, node, metastasis
U-VATS	Uniportal video-assisted thoracoscopic surgery